Susan Brandzel cues up our tunes as we look ahead to better days in the new year.
Kaiser Permanente Washington shows price may not be a barrier to primary care implementation, Dr. Kai Yeung reports.
Dr. Diana Buist reflects on the challenges of providing screening during a pandemic — and finds reason for optimism.
The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.
This year’s honorees inspire us with their unwavering dedication to helping colleagues grow and achieve – even from a distance.
KPWHRI responded to the COVID-19 hurricane with actions to improve health worldwide.
In a Viewpoint for JAMA, KPWHRI’s Dr. Mike Jackson plans ahead to meet the challenges of continuing to evaluate new vaccines.
